Latest news
Iconovo carries out a directed issue of shares of approx. SEK 25 million and a rights issue of shares of approx. SEK 24.6 million
The Board of Directors of Iconovo AB ("Iconovo" or the "Company") has today resolved on a directed share issue of approximately SEK 25 million (the…
Iconovo appoints Anders Månsson as new CEO
Iconovo AB (publ), a leader in the development of inhalable drugs based on proprietary inhalers and dry powder formulations, has today appointed Anders…
Press releases
Dec 15, 2022, 16:45
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Dec 15, 2022, 16:45
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Staff change
Dec 07, 2022, 11:50
News
IR
English
Corporate Information
Other Corporate Information
Dec 07, 2022, 11:45
News
IR
Swedish
Corporate Information
Other Corporate Information
Nov 16, 2022, 08:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Nov 08, 2022, 17:30
News
IR
English
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 08, 2022, 17:30
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Nomination Committee
Nov 03, 2022, 12:10
News
IR
English
Corporate Information
Other Corporate Information
Oct 28, 2022, 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q3
Oct 24, 2022, 08:30
News
IR
Swedish
Corporate Information
Other Corporate Information
Oct 24, 2022, 08:30
News
IR
English
Corporate Information
Other Corporate Information
Aug 12, 2022, 17:00
News
IR
Swedish
Regulatory
Listing Regulation
Corporate Information
Staff change
Jul 26, 2022, 08:00
News
IR
Swedish
Regulatory
MAR
Corporate Information
Other Corporate Information
Jul 26, 2022, 08:00
News
IR
English
Regulatory
MAR
Corporate Information
Other Corporate Information
Jul 18, 2022, 08:00
News
IR
English
Corporate Information
Other Corporate Information
Jul 15, 2022, 08:00
News
IR
Swedish
Regulatory
MAR
Report
Interim
Q2
Jun 13, 2022, 14:00
News
IR
English
Corporate Information
Other Corporate Information
Jun 13, 2022, 14:00
News
IR
Swedish
Corporate Information
Other Corporate Information
Jun 07, 2022, 11:10
News
IR
Swedish
Corporate Information
Other Corporate Information
Jun 07, 2022, 11:10
News
IR
English
Corporate Information
Other Corporate Information
Possessing a unique combination
of engineering and pharma expertise, Iconovo can provide the optimal combination of customized inhalers and tailored formulations.
ICONOVO AB
VISITING ADDRESS
Ideon, Delta 6 Lund
Ideongatan 3B
POSTAL ADDRESS
Iconovo AB
Ideongatan 3A-B
SE-223 62 LUND
Sweden
CONTACT
Phone: +46 46 275 67 77
Director Business Development and Alliances
Måns Österberg
Mail: mans.osterberg@iconovo.se
Interim CEO
Anders Månsson
Mail: anders.mansson@iconovo.se